ETF Components for VIRS - Pacer BioThreat Strategy ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
WMT A 0.29 5.27
JNJ D 0.17 5.21
ABT A 4.61 5.00
TMO D 2.12 4.92
SNY D 0.74 4.89
LOW B 0.04 4.89
HD B -0.29 4.86
DHR D 0.85 4.83
NFLX A 0.01 4.80
REGN F 0.64 4.52

Recent News for Pacer BioThreat Strategy ETF & its Holdings

Date Stock Title
Nov 2 HD Best Stock to Buy Right Now: Home Depot vs. Lowe's
Nov 1 HD How a Working Mom Shrewdly Managed a Lake House Remodeling
Nov 1 SNY Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
Nov 1 ABT Stocks that hedge funds moved from long to short in August - Jefferies
Nov 1 JNJ Stocks that hedge funds moved from long to short in August - Jefferies
Nov 1 ABT Abbott, Reckitt found not liable in baby formula case. Stocks rise.
Nov 1 NFLX Netflix has ‘won’ the streaming wars — here’s how others will compete
Nov 1 WMT Walmex to implement Quorso’s Co-Pilot across its 2,850 stores
Nov 1 ABT Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
Nov 1 SNY Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
Nov 1 HD Operation Surprise 2024: The Home Depot Foundation's Tribute to Service
Nov 1 ABT Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
Nov 1 ABT Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win
Nov 1 DHR Here’s Why Baron Health Care Fund Added Danaher Corporation (DHR) to its Portfolio
Nov 1 WMT Zealous advocacy? No, call it lawyer betrayal instead, professor says
Nov 1 ABT Abbott shares rise following baby formula verdict
Nov 1 REGN What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Nov 1 ABT Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
Nov 1 JNJ Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase
Nov 1 JNJ J&J Medtech CIO Larry Jones resigns
An exchange traded fund (ETF) that seeks to track the LifeSci BioThreat Strategy Index to invest in U.S. listed companies whose products or services help to protect against, endure or recover from biological threats to human health. The index aims to: Research of current and future pandemics. Combat agents of biological warfare. Detect the presence of biological threats. Secure national borders and ports and strengthen homeland security. Aid in stockpiling of products needed in times of natural disasters and disease outbreaks. Improve food and water safety and purity. Enable technology to benefit work and stay at home mandates.
Exchange Traded Fund Computing Disease Computer Security Homeland Security Biological Warfare Information Age Bioethics
Back to the Main VIRS Page...